News

Find News

Filter articles

Applied Filters

Showing 801 to 810 of 910 results

Pfizer and Mylan reach Celebrex agreement

US02-06-2014Legal developments

Pfizer and Mylan have agreed to settle litigation related to arthritis treatment Celebrex (celecoxib), Mylan announced today, June 2.

Acura ends all Aversion litigation with final Sandoz settlement

US23-05-2014Legal developments

US-based drug company Acura and Novartis’s generic arm Sandoz have settled their patent infringement dispute related to an abuse-deterrent formulation of the painkiller Aversion (oxycodone).

UNDP urges use of competition law to boost healthcare access

20-05-2014

The United Nations Development Programme has released a guidebook for low- to middle- income countries on how to increase access to essential health technologies and HIV treatments by using competition law and policy.

US court denies Teva’s final shot at blocking Copaxone copies

US19-05-2014Legal developments

A US district court has dismissed Teva’s case against the FDA aimed at stopping the administration from approving generic versions of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).

Lilly’s Alimta dosage patent invalidated at English High Court

UK16-05-2014Legal developments

The English High Court has ruled that a patent covering vitamin dosage regimens for Eli Lilly’s lung cancer drug Alimta (pemetrexed disodium) would not be infringed by generic competitors.

Sun and Novartis settle on Gleevec

US15-05-2014

Novartis and Sun Pharma’s US subsidiary have settled litigation related to cancer drug Gleevec (imatinib mesylate) in the US, the companies announced today (May 15).

Janssen sues to halt Mylan’s Concerta generic

US14-05-2014Legal developments

Johnson & Johnson’s pharmaceuticals subsidiary Janssen has sued Mylan to stop it launching a generic version of Concerta (methylphenidate hydrochloride).

Valeant agrees to license Acanya in Actavis settlement

US13-05-2014Legal developments

Canadian pharmaceutical company Valeant announced yesterday (May 12) that it had settled all litigation related to its acne treatment Acanya (clindamycin phosphate and benzoyl peroxide) with Actavis.

Acura settles Oxecta dispute with Ranbaxy

US08-05-2014Legal developments

Acura Pharmaceuticals and Ranbaxy have agreed to settle their patent infringement litigation related to painkiller Aversion (oxycodone hydrochloride), once marketed by Pfizer under its registered trademark Oxecta.

FTC weighs in on “no-authorised-generic” antitrust case

US07-05-2014

The US Federal Trade Commission (FTC) has filed an amicus brief in an antitrust case that concerns a “no-authorised-generic” settlement between Teva and GlaxoSmithKline (GSK).

Showing 801 to 810 of 910 results

LSIPR